JUN 10, 2020 3:17 PM PDT

Cannabis Temporarily Relieves PTSD Symptoms

WRITTEN BY: Annie Lennon

PTSD (Post Traumatic Stress Disorder) is a mental disorder characterized by flashbacks, nightmares, and severe anxiety following a terrifying event. With no concrete cure, researchers from Washington State University have found that cannabis may provide short-term relief from PTSD symptoms. 

Currently, physicians usually recommend psychotherapy as a first-line treatment for PTSD. However, as cannabis products become more available, more and more people are thought to be self-medicating with the plant, according to the researchers. They thus wanted to understand how effective it may be in relieving the mental condition. 

To do so, they examined data from 404 people who tracked changes in their PTSD symptoms before and after using cannabis. They used Strainprint, an app that helps users learn which types of medical marijuana work best for them to relieve their symptoms. Collectively, they used the app more than 11,000 times over 31 months. 

The researchers found that cannabis is able to reduce multiple PTSD symptoms temporarily. In particular, the plant was found to reduce numbers of recurring thoughts following a traumatic event by around 62% and irritability by 67%. The study also found that flashbacks decreased by 51% and anxiety by 57%. 

“The study suggests that cannabis does reduce symptoms of PTSD acutely, but it might not have longer term beneficial effects on the underlying condition,” said Carrie Cuttler, lead author of the study. “Working with this model, it seems that cannabis will temporarily mask symptoms, acting as a bit of a band aid, but once the period of intoxication wears off, the symptoms can return.”

Although suggestive of the benefits of cannabis against PTSD in the short term, the researchers note that their results may be inconclusive. This comes as the study relied on a self-selected sample of people who self-identify as having the mental disorder, as opposed to patients who had received a clinical diagnosis. The authors also note that they had no control group with which to compare results.


Sources: Neuroscience News, Washington State University, Science Direct

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
SEP 10, 2020
Cannabis Sciences
Legalizing Cannabis Does Not Lead to Teenage Substance Abuse
SEP 10, 2020
Legalizing Cannabis Does Not Lead to Teenage Substance Abuse
Some say that decriminalizing cannabis may lead to an uptick in young people abusing the substance. Countering this fear ...
SEP 20, 2020
Cannabis Sciences
Can Cannabis be Used to Treat Autism?
SEP 20, 2020
Can Cannabis be Used to Treat Autism?
Currently, the consensus on whether cannabis may be used to treat autism is mixed. While some papers show signs of its p ...
NOV 10, 2020
Health & Medicine
Users of Medical Cannabis Reduce Their Alcohol Intake
NOV 10, 2020
Users of Medical Cannabis Reduce Their Alcohol Intake
Results from the Canadian Cannabis Patient Survey 2019 (CCPS 2019), a large cross-sectional survey of medical cannabis p ...
NOV 14, 2020
Cannabis Sciences
New Genetic Test Identifies Cannabis THC Levels from Seeds
NOV 14, 2020
New Genetic Test Identifies Cannabis THC Levels from Seeds
Researchers from the University of Minnesota have developed a genetic test that can predict how much cannabidiol (CBD) o ...
NOV 14, 2020
Cannabis Sciences
Half of CBD Users Test Positive for THC in Urine Tests
NOV 14, 2020
Half of CBD Users Test Positive for THC in Urine Tests
Despite the growing popularity of cannabidiol (CBD) products, there has been little research directly assessing whether ...
DEC 31, 2020
Plants & Animals
Could CBD be a food preservative?
DEC 31, 2020
Could CBD be a food preservative?
CBD (cannbidiol) oil from has many claims made for it — and now lengthening the shelf life of fresh fruit could fe ...
Loading Comments...